The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJz Capital Regulatory News (JZCP)

Share Price Information for Jz Capital (JZCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 215.00
Bid: 192.00
Ask: 238.00
Change: 0.00 (0.00%)
Spread: 46.00 (23.958%)
Open: 215.00
High: 216.00
Low: 215.00
Prev. Close: 215.00
JZCP Live PriceLast checked at -
JZ Capital Partners is an Investment Trust

The strategy is to realise investments, pay down debt and reduce commitments to new investments. In addition, the company will return capital to Shareholders while meeting the capital requirements of the portfolio in order to achieve NAV growth.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q1 2017 Interim Management Statement

29 Jun 2017 07:00

JZ Capital Partners Ltd - Q1 2017 Interim Management Statement

JZ Capital Partners Ltd - Q1 2017 Interim Management Statement

PR Newswire

London, June 29

JZ CAPITAL PARTNERS LIMITED(a closed-end investment company incorporated with limited liability under the laws of Guernsey with registered number 48761)

 Q1 2017 Interim Management Statement29 June 2017

JZ Capital Partners Limited (LSE: JZCP.L, the “Company” or “JZCP”), the London listed fund that invests in US and European micro-cap companies and US real estate, today releases its Interim Management Statement for the period 1 March 2017 to 31 May 2017.

Results Highlights

Net Asset Value (“NAV”) of $833.3 million (28/02/17: $848.8 million) NAV per share of $9.93 (28/02/17: $10.12) $43.9 million invested during the period, including: $12.0 million invested in new co-investment Felix Storch $4.5 million follow-on investment in Jordan Health Products $1.2 million net investment in Reflective Apparel Factory (“RAF”), a Technical Services and Solutions (“TSS”) vertical add-on acquisition $16.3 million realised, including: $12.5 million from the first tranche of proceeds for Fidor Bank At the end of the period, the portfolio consisted of 34 micro-cap investments across nine industries and four major real estate “assemblages” (59 total properties) located in New York and South Florida

Strategic Initiatives

In May 2017, JZCP received shareholder approval for certain initiatives designed to maximize shareholder returns, including the discontinuation of the Company’s current dividend policy and inception of a new strategy to allow for the repurchase of shares In April 2017, JZCP increased its loan facility with Guggenheim Partners from approximately $100 million to $150 million in order to provide additional liquidity to JZCP in order to bridge certain planned realisations. The entire $150 million facility may be repaid, in whole or in part, with no penalty after June 2017

David Zalaznick, Founder and Investment Advisor of JZCP said: “Despite the challenging market environment, the strength of our balance sheet has again allowed us to put money to work across the US and European micro-cap and US real estate sectors.

We continue to believe that the US market presents a number of potential realisation opportunities for the Company and we remain confident in the outlook for our diversified portfolio.”

Net Asset Value

NAV per share for the quarter decreased from $10.12 to $9.93, or 1.9%.

NAV Returns

Net Asset Value per Ordinary Share as of 1 March 2017$10.12
Change in NAV per share due to capital gains and income received / accrued on investments
US Micro-cap0.03
European Micro-cap (0.05)
Real Estate (0.06)
Other Investment (0.06)
Other changes in NAV per share
Change in CULS Fair Value (0.01)
Finance Costs (0.06)
Foreign Exchange Effect0.08
Expenses and Taxation (0.04)
Net Asset Value per Ordinary Share as of 31 May 2017 $9.93

The US micro-cap portfolio had a net increase of 3 cents, primarily due to net accrued income of 5 cents and write-ups at our healthcare revenue cycle management vertical (2 cents) and logistics vertical (1 cent). Jordan Health Products was also written up 2 cents. An escrow payment related to our exited co-investment Medplast added 1 cent. Offsetting these uplifts in valuation were decreases in value at our legacy Nationwide Studios business (1 cent) and our ISS vertical (9 cents).

The European micro-cap portfolio had a net decrease of 5 cents, primarily due to 1cent of accrued income offset by a 6 cent write-down at Factor Energia.

The real estate portfolio had a net decrease of 6 cents, primarily due to estimates of debt service, operating costs and other expenses at the property level.

Finally, our other investments had a net decrease of 6 cents, primarily due to a write-down at Spruceview (6 cents).

The chart below summarises the cumulative total NAV returns and total shareholder returns for the most recent three-month, twelve-month, three-year and five-year period.

31/05/17Since 28/02/17Since 31/05/16Since 31/05/14Since 31/05/12
Share price (in GBP)£5.66£5.38£3.90£4.41£3.68
Dividends paid (in USD)$0.16$0.79$1.57
Total Shareholders' return (GBP)15.2%48.9%45.3%95.0%
NAV per share (in USD)$9.93$10.12$10.32$10.08$9.38
NAV per share total returns1(1.9)%(2.3)%6.5%24.2%
NAV to market price discount26%34%45%27%40%

______________

Total returns are cumulative and assume that dividends were reinvested

RECENT ACTIVITIES

Significant Investments and Realisations

US Micro-cap Investments – Verticals

TSS Vertical (formerly known as ‘testing’ vertical)

In May 2017, JZCP invested $1.2 million (investment net of proceeds from refinancing the entire testing vertical) to acquire RAF, which produces high-end reflective apparel purchased by transportation, municipal, construction and industrial customers.

US Micro-cap Investments – Co-investments

In March 2017, JZCP invested a further $4.5 million in Jordan Health Products, to fund the acquisition of Transtate, a business which sells, services, repairs and installs refurbished medical imaging equipment, specializing in catheter angiography equipment.

Also in March 2017, JZCP invested $12.0 million in Felix Storch, a business that manufactures and distributes specialty refrigeration products and appliances.

European Micro-cap Investments

In April and May 2017, JZCP made three short-term loans to EuroMicrocap Fund-B, L.P., totalling $5.4 million, to bridge investments in Docout, Ombuds and One World Packaging.

We expect these loans to be paid back before their stated maturity dates of 31 July 2017.

Real Estate Investments

In the three-month period ended 31 May 2017, JZCP invested a total of $10.4 million in follow-on investments in our Williamsburg Retail, Design District and Greenpoint properties.

Realisations

JZCP sold its interest in Fidor Bank (“Fidor”) to Groupe BPCE, the second largest banking group in France. The transaction closed in December 2016. JZCP invested a total of $13.8 million and is expected to receive total gross proceeds of approximately $25 million from the sale. JZCP received its first tranche of proceeds totalling $12.5 million in March 2017.

PORTFOLIO SUMMARY

At 31 May 2017, the Company’s portfolio consisted of 34 micro-cap investments across nine major industries and four major real estate “assemblages” (59 total properties) located in New York and South Florida.

($’000)At 31/05/17At 28/02/17% Gross Assets 31/05/17
US Micro-cap Portfolio442,147424,50238.9%
European Micro-cap Portfolio162,183154,27714.2%
Real Estate Portfolio474,758468,59941.7%
Other Portfolio15,84421,8021.4%
Total Private Investments1,094,9321,069,18096.2%
Cash42,26229,0643.7%
Total Investments (and Cash)1,137,1941,098,24499.9%
Other Current Assets5965110.1%
Total Investments (and Cash)1,137,7901,098,755100.0%

At 31 May 2017, 3.7% of gross assets were invested in “liquid” assets (cash). The remaining portion of the portfolio was invested in private investments in US or European micro-cap companies or real estate. These investments are valued at fair value by JZCP’s directors each quarter.

We value our privately held businesses carefully. Our average multiple used for our US micro-cap businesses is 8.2x trailing EBITDA. In addition, we do not have substantial debt in these businesses. The multiple of debt senior to JZCP’s position is approximately 3.4x EBITDA.

Top Ten Investments

Our ten largest investments as of 31 May 2017 are summarised below:

($000’s)Asset CategoryValuation 31/05/17% Gross Assets 31/05/17
Design District AssemblageReal Estate100,5708.8%
Industrial Services Solutions VerticalUS77,6536.8%
GreenpointReal Estate75,5246.6%
Healthcare Rev. Cycle Management VerticalUS70,2736.2%
Williamsburg RetailReal Estate68,7186.0%
Fulton AssemblageReal Estate62,0115.5%
EuroMicrocap Fund-C, L.P.European61,0775.4%
TierPointUS46,8134.1%
Jordan Health ProductsUS37,3543.3%
RedBridgeReal Estate36,4453.2%
Top Ten Investments636,43855.9%
Remaining Assets501,35244.1%
Gross Assets1,137,790100.0%

Balance Sheet

Below is a summary of JZCP’s balance sheet as of the relevant dates:

($000’s)31/05/1728/02/17
Cash and cash equivalents42,26229,064
Investments & other assets1,095,5281,069,691
(-) Other net liabilities(247,780)(195,976)
(-) ZDPs due 2022(56,669)(53,935)
Net Asset Value833,341848,844

At 31 May 2017, “other net liabilities” includes $60.2 million from the issuance of Convertible Unsecured Loan Stock (“CULS”) in July 2014, which carries an interest rate of 6%, and $147.6 million from a six-year term loan with Guggenheim Partners, which carries an interest rate of LIBOR plus 5.75%.

For Further Information:

Ed Berry / Kit Dunford +44 (0) 20 3727 1046 / 1143FTI Consulting

David Zalaznick +1 212 485 9410Jordan/Zalaznick Advisers, Inc.

Teresa Le Couteur-Tembo +44 (0) 1481 745741JZ Capital Partners, Ltd.

About JZCP

JZCP is a London listed fund which invests in US and European micro-cap companies and US real estate. Its objective is to achieve an overall return comprised of a current yield and capital appreciation. JZCP receives investment advice from Jordan/Zalaznick Advisers, Inc. (“JZAI”) which is led by David Zalaznick and Jay Jordan. They have worked together for 30 years and are supported by teams of investment professionals in New York, Chicago, London and Madrid. JZAI’s experts work with the existing management of micro-cap companies to help build better businesses, create value and deliver strong returns for investors. JZCP also invests in mezzanine loans, first and second lien investments and other publicly traded securities. For more information please visit www.jzcp.com.

Date   Source Headline
31st Mar 20113:46 pmRNSTotal Voting Rights
15th Mar 20115:07 pmRNSCapital Reorganisation
16th Feb 201110:24 amRNSNet Asset Value(s)
21st Jan 20119:02 amRNSNet Asset Value(s)
23rd Dec 201012:26 pmRNSResult of EGM
21st Dec 20104:26 pmRNSNet Asset Value(s)
21st Dec 20107:00 amRNSInterim Management Statement
14th Dec 201010:38 amRNSDisposal
9th Dec 201010:36 amRNSHolding(s) in Company
30th Nov 20107:00 amRNSEurope Fund arrangements, Fund A Documents
22nd Nov 20108:37 amRNSNet Asset Value(s)
28th Oct 20103:45 pmRNSNet Asset Value(s)
28th Oct 20107:00 amRNSHalf Yearly Report
6th Oct 20106:20 pmRNSDirector Declaration
17th Sep 20109:00 amRNSNet Asset Value(s)
19th Aug 20109:30 amRNSNet Asset Value(s)
27th Jul 20103:30 pmRNSNet Asset Value(s)
12th Jul 201011:28 amRNSDirector Declaration
22nd Jun 20102:00 pmRNSNet Asset Value(s)
22nd Jun 20107:00 amRNSInterim Management Statement
22nd Jun 20107:00 amRNSResult of AGM
28th May 20103:45 pmRNSNet Asset Value(s)
19th May 20108:45 amRNSNet Asset Value(s)
18th May 20107:00 amRNSFinal Results
13th May 201011:02 amRNSNotice of Results
30th Mar 201011:30 amRNSNet Asset Value(s)
4th Mar 20107:00 amRNSDividend Declaration
1st Mar 201010:00 amRNSNet Asset Value(s)
10th Feb 201010:00 amRNSNet Asset Value(s)
21st Dec 200911:30 amRNSNet Asset Value(s)
21st Dec 20097:00 amRNSInterim Management Statement
20th Nov 200910:30 amRNSNet Asset Value(s)
30th Oct 20092:00 pmRNSNet Asset Value(s)
30th Oct 20097:00 amRNSInterim Results
6th Oct 200910:00 amRNSNet Asset Value(s)
20th Aug 20093:58 pmRNSNet Asset Value(s)
3rd Aug 20092:03 pmRNSNet Asset Value(s)
16th Jul 20092:45 pmRNSResult of AGM
3rd Jul 200911:51 amRNSInterim Management Statement
2nd Jul 20096:12 pmRNSHolding(s) in Company
30th Jun 20094:07 pmRNSTotal Voting Rights
25th Jun 20094:57 pmRNSHolding(s) in Company
24th Jun 200912:15 pmRNSDirector/PDMR Shareholding
23rd Jun 200911:58 amRNSNotice of AGM
19th Jun 20094:40 pmRNSSecond Price Monitoring Extn
19th Jun 20094:35 pmRNSPrice Monitoring Extension
18th Jun 20094:40 pmRNSSecond Price Monitoring Extn
18th Jun 20094:35 pmRNSPrice Monitoring Extension
18th Jun 20092:09 pmRNSFurther re Dividend
18th Jun 20092:08 pmRNSResult of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.